首家汽車芯片企業總部落戶湖北省
據《湖北日報》報道,吉利控股參投的湖北芯擎科技,昨日(20日)與湖北長江經開汽車產業投資基金在漢達成戰略合作,位於武漢經開區的湖北芯擎科技有限公司武漢總部同步開業。
該公司為湖北省首家車載芯片研發設計企業,明年起由湖北芯擎自主研發的、達到國際領先水平的7納米車載芯片將問世,結束內地高端車載芯片依賴進口的歷史。
湖北芯擎科技有限公司CEO汪凱表示,將於明年問世的芯擎第一代智能駕艙芯片,將對標國際領先產品,可滿足汽車主機廠對於高性能、寬應用、強安全、5G互聯、人工智能等技術需求。目前公司正在與包括吉利汽車(00175.HK)在內的湖北省內外車企技術對接,提升國產車載芯片適配性,為批量生產做準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.